Korea Biomedical Review
| Format | Online[1] |
|---|---|
| Founded | February 22, 2017 |
| Language | English |
| Headquarters | Seoul, Korea |
| Sister newspapers | Korean Doctors' Weekly |
| Website | koreabiomed.com[2] |
Korea Biomedical Review[3] (Korean: 코리아 바이오메디칼 리뷰), abbreviated as KBR,[4] is a South Korea-based[5] online English-language newspaper that mainly delivers news related to the field of healthcare in the Republic of Korea.[6]
Korea Biomedical Review is the first English newspaper in South Korea focusing on the healthcare field,[7] and its ISO 4 abbreviation is Korea Biomed. Rev..[8]
The newspaper's official website domain name, koreabiomed.com,[9] was registered on October 7, 2016.[10] The first issue of Korea Biomedical Review was released on 22 February 2017 as a sister paper to its Korean version, the Korean Doctors' Weekly.[11]
References
[edit]- ^ Sabrina Ching Yuen Luk (6 January 2020). Ageing, Long-term Care Insurance and Healthcare Finance in Asia. Routledge. pp. 2023–. ISBN 978-1-351-63134-1.
- ^ OECD (31 March 2020). OECD Reviews of Public Health: Korea A Healthier Tomorrow: A Healthier Tomorrow. OECD Publishing. pp. 130–. ISBN 978-92-64-68964-0.
- ^ "Korean professors indicted in admissions case tied to politics". Times Higher Education. Jan 3, 2020.
- ^ "[South Korean medical scandal] It is reported that more than 100 doctors have been involved in receiving rebates from pharmaceutical factories, with a total amount of nearly 30 million Hong Kong dollars". Ming Pao. 2018-10-10.
- ^ Simone Gold, M.D., J.D. (15 October 2020). I Do Not Consent: My Fight Against Medical Cancel Culture. Bombardier Books. pp. 57–. ISBN 978-1-64293-891-3.
((cite book)): CS1 maint: multiple names: authors list (link) - ^ "Will a World Directory's Delisting Of Chinese Medicine Schools Affect TCM's Status?". Beijing Review. 2019-11-29.
- ^ "[Congratulatory message] President of KDA Choi Nam-sup". Korea Biomedical Review. 2017-02-24.
- ^ Tsutomu Takeuchi.Takeuchi, Tsutomu; Tanaka, Yoshiya; Tanaka, Sakae; Kawakami, Atsushi; Song, Yeong-Wook; Chen, Yi-Hsing; Rokuda, Mitsuhiro; Izutsu, Hiroyuki; Ushijima, Satoshi; Kaneko, Yuichiro; Nakashima, Yoshihiro; Shiomi, Teruaki; Yamada, Emi (12 March 2020). "Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan". Arthritis Research & Therapy. 22 (1): 47. doi:10.1186/s13075-020-2125-2. PMC 7068874. PMID 32164762.
- ^ Larry D. Purnell; Eric A. Fenkl (5 September 2020). Textbook for Transcultural Health Care: A Population Approach: Cultural Competence Concepts in Nursing Care. Springer Nature. pp. 610–. ISBN 978-3-030-51399-3.
- ^ "KoreAbiomed.com WHOIS, DNS, & Domain Info – DomainTools". WHOIS. Retrieved October 24, 2020.
- ^ Lee Kyung-min (Mar 19, 2017). "Sunlight is the best disinfectant - The Korea Times". The Korea Times.
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.
Cover photo is available under {{::mainImage.info.license.name || 'Unknown'}} license.
Cover photo is available under {{::mainImage.info.license.name || 'Unknown'}} license.
Credit:
(see original file).
